Health Care & Life Sciences » Pharmaceuticals | AstraZeneca PLC

AstraZeneca PLC | Mutual Funds

Mutual Funds that own AstraZeneca PLC

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Health Care Fund
35,227,181
2.78%
-665,301
5.28%
06/30/2018
Government Pension Fund - Global (The)
25,809,093
2.04%
3,630,973
0.23%
12/31/2017
American Funds Income Fund of America
18,539,107
1.46%
2,095,000
1.41%
06/30/2018
Vanguard Total International Stock Index Fund
18,039,599
1.42%
278,680
0.38%
07/31/2018
Dodge & Cox International Stock Fund
17,055,100
1.35%
-114,400
2.17%
06/30/2018
Franklin Income Fund
12,000,000
0.95%
0
1.09%
03/31/2018
Vanguard Developed Markets Index Fund
7,148,234
0.56%
-5,712
0.49%
07/31/2018
iShares MSCI EAFE ETF
6,220,864
0.49%
0
0.66%
09/06/2018
Invesco Perpetual UK Invt. Ser. - High Income
5,955,928
0.47%
-763,208
3.63%
03/29/2018
Threadneedle Invt. Funds ICVC-UK Equity Income Fund
5,523,057
0.44%
20,452
7.51%
04/30/2018

About AstraZeneca

View Profile
Address
Cambridge Biomedical Campus
Cambridge Cambridgeshire CB2 0AA
United Kingdom
Employees -
Website http://astrazeneca.com
Updated 07/08/2019
AstraZeneca Plc is a holding company, which engages in the research, development and manufacturing of pharmaceutical products. The company produces and commercializes medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases. Its pipeline consists of azd 4831, azd 8601, medi 0382, tagrisso bloom, durvalumab, selumetinib, lyparza polo, epanova, farxiga and brilinta.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.